Product
Ondansetron
Aliases
5-HT3 receptor antagonist, Danset ampoule, Ondansetron 4 mg, Ondansetron 8mg (5 other aliases)
Name
Ondansetron
INN Name
Ondansetron Tablets
FDA Approved
Yes
57 clinical trials
1 organization
77 indications
1 document
Indication
GastroenteritisIndication
Postoperative Nausea and Vomiting (PONV)Indication
Small Cell Lung CancerIndication
Extra-Pulmonary Small Cell CarcinomasIndication
Post-operative Nausea and VomitingIndication
Sleeve GastrectomyIndication
Obsessive-Compulsive DisorderIndication
Tic DisordersIndication
Tourette syndromeIndication
Injection Site IrritationIndication
DyspepsiaIndication
Diabetes MellitusIndication
Postoperative Nausea and VomitingIndication
Laparoscopic Sleeve GastrectomyIndication
Severe ObesityIndication
NauseaIndication
VomitingIndication
Ondansetron LozengeIndication
Cesarean SectionIndication
Post-Dural Puncture HeadacheIndication
Cyclic Vomiting SyndromeIndication
Perioperative OptimizationIndication
Gynecologic CancerIndication
Adverse EffectIndication
HealthyIndication
Hyperemesis GravidarumIndication
Nausea GravidarumIndication
Nausea and Vomiting of PregnancyIndication
Atrial FibrillationIndication
Neuropathic PainIndication
Gallbladder RemovalIndication
Pediatric Solid TumorIndication
UnspecifiedIndication
Protocol SpecificIndication
Abdominal PainIndication
Inflammatory Bowel DiseaseIndication
Eosinophilic GastroenteritisIndication
DiarrheaIndication
Rectal bleedingIndication
Unintentional Weight LossIndication
Cannabis Use DisorderIndication
Sleep SyncopeIndication
Chemotherapy-induced nausea and vomitingIndication
Acute GastroenteritisIndication
Viral InfectionIndication
Chemotherapy-induced Nausea and VomitingIndication
Juvenile Idiopathic ArthritisIndication
ScoliosisIndication
IBS - Irritable Bowel SyndromeIndication
Acute Respiratory Distress SyndromeIndication
Fibrosis of the LiverIndication
Alpha-1 Antitrypsin DeficiencyIndication
Alpha-1 antitrypsin deficiencyIndication
Cannabis UseIndication
Pediatric CancerIndication
Anesthesia ComplicationsIndication
Thoracic DiseasesIndication
Alcohol abuseIndication
Alcohol use disorderIndication
CancerIndication
Parkinson's Disease HallucinationsIndication
Dementia with Lewy BodiesIndication
Drug-induced PruritusIndication
CoagulopathyIndication
SepsisIndication
Septic shockIndication
PostoperativeIndication
Cesarean Section ComplicationsIndication
Vasovagal SyncopeIndication
SyncopeIndication
PediatricsIndication
StrabismusIndication
Post-Spinal ShiveringIndication
c-sectionIndication
NephrotoxicityClinical trial
A Randomized, Double-Blinded, Placebo-Controlled, Phase III Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the Treatment of Nausea and Vomiting in Adult Patients With Acute GastroenteritisStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk SubjectsStatus: Completed, Estimated PCD: 2022-03-07
Clinical trial
Phase I/II Trial of PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell CancersStatus: Active (not recruiting), Estimated PCD: 2021-08-13
Clinical trial
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve GastrectomyStatus: Completed, Estimated PCD: 2019-03-30
Clinical trial
Effects of Ondansetron in Obsessive-compulsive and Tic DisordersStatus: Completed, Estimated PCD: 2022-05-16
Clinical trial
Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and DyspepsiaStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Comparative Clinical Study Among Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve GastrectomyStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Antiemetic Fosaprepitant To Remedy Nausea and VomitingStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Caesarean Section: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia for Cesarean Sections : A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Comparison of Haloperidol 5mg IM vs Droperidol 2.5mg and Ondansetron for the Treatment of Hyperemesis in Cannabis Hyperemesis SyndromeStatus: Terminated, Estimated PCD: 2023-11-20
Clinical trial
Randomized, Embedded, Multifactorial Adaptive Platform for Perioperative Medicine at UPMC (UPMC REMAP): Core Protocol - Enhanced Recovery Protocols (ERP)Status: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Phase III Randomized Control Trial Investigating Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Patients With Gynecologic Malignancies Receiving Every 3-week Carboplatin and Paclitaxel ChemotherapyStatus: Terminated, Estimated PCD: 2024-01-03
Clinical trial
Ondansetron for Postspinal Anesthesia Hypotension in Patients Undergoing Cesarean Section: A Randomized, Controlled TrialStatus: Completed, Estimated PCD: 2023-10-27
Clinical trial
Single-Dose Food In Vivo Bioequivalence Study of Ondansetron Orally Disintegrating Tablets (8 mg; Mylan) to Zofran ODT® Tablets (8 mg; GlaxoSmithKline) in Healthy VolunteersStatus: Completed, Estimated PCD: 2005-07-01
Clinical trial
Trial of Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy: A Pilot InvestigationStatus: Completed, Estimated PCD: 2022-10-17
Clinical trial
Inhibition of Small Conductance Calcium-Activated Potassium Current: A New Therapeutic Approach for Atrial FibrillationStatus: Recruiting, Estimated PCD: 2027-12-31
Clinical trial
Oral Granisetron Versus Oral Ondansetron for Treatment of Gastroenteritis: A Randomized Controlled Clinical TrialStatus: Completed, Estimated PCD: 2023-11-11
Clinical trial
Administration of Ondansetron With P-glycoprotein Inhibitor Tariquidar in Patients With Neuropathic PainStatus: Completed, Estimated PCD: 2023-10-21
Clinical trial
Comparative Efficacy of Dexamethasone - Ondansetron Versus Dexamethasone - Haloperidol in Reducing Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Randomized Controlled TrialStatus: Completed, Estimated PCD: 2024-02-28
Clinical trial
Efficacy of Ondansetron Oral Soluble Film Combined With Dexamethasone Versus Ondansetron Intravenously Combined With Dexamethasone in Prophylaxis of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients : A Multi-center, Randomized, Parallel Controlled, Non-inferior Clinical Study.Status: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
Examining the Effect of Ondansetron on Bowel Prep SuccessStatus: Completed, Estimated PCD: 2023-07-01
Clinical trial
Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized Controlled TrialStatus: Completed, Estimated PCD: 2019-06-30
Clinical trial
Randomized, Prospective, Placebo-Controlled, Crossover Study of Ondansetron in the Prevention of Sleep Syncope: The Nineth Prevention of Syncope Trial (POST9)Status: Not yet recruiting, Estimated PCD: 2026-12-31
Clinical trial
Comparative Study on the Efficacy and Safety of Ondansetron Oral Membrane for the Prevention of Vomiting During Moderate Hypoemetic ChemotherapyStatus: Not yet recruiting, Estimated PCD: 2024-12-30
Clinical trial
Multi-dose Oral Ondansetron For Pediatric Gastroenteritis: A Pragmatic Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Phase II Trial Testing the Antiemetic Efficacy of a Single-day Low Dose Aprepitant (or Fosaprepitant) Added to a 5-HT3 Receptor Antagonist Plus Dexamethasone in Patients Receiving CarboplatinStatus: Terminated, Estimated PCD: 2021-02-11
Clinical trial
The Ondansetron Premedication Trial in Juvenile Idiopathic ArthritisStatus: Active (not recruiting), Estimated PCD: 2024-10-01
Clinical trial
A Comparison Between Palonosetron And Ondansetron As Prophylaxis Against Postoperative Nausea and Vomiting In Idiopathic Scoliosis Surgery: A Randomised TrialStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
A Randomised, Placebo Controlled Trial to Determine the Efficacy and Mode of Action of Ondansetron in the Treatment of Irritable Bowel Syndrome With DiarrhoeaStatus: Completed, Estimated PCD: 2020-08-03
Clinical trial
Effect of a 5-HT3 Receptor Antagonist on Respiratory Drive in Spontaneously Breathing Mechanically Ventilated Patients With Acute Respiratory Distress Syndrome (ARDS): a Pilot Proof-of-concept Crossover Non-randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-03-06
Clinical trial
Phase II Randomized Study to Evaluate Efficacy, Patient Satisfaction, and Compliance of the Oral Combination of Rolapitant (Varubi®) Plus Ondansetron vs. Ondansetron Monotherapy in Malignant Glioma Patients Receiving Radiotherapy (RT) and Concomitant TemozolomideStatus: Completed, Estimated PCD: 2022-05-09
Clinical trial
Clinical Predictors and Epigenetic Markers for Liver Fibrosis in Alpha-1 Antitrypsin DeficiencyStatus: Completed, Estimated PCD: 2019-09-01
Clinical trial
A Single Center, Randomized Controlled Prospective Double-blinded Trial Comparing Haloperidol to Standard Ondansetron Therapy for Control of Nausea and Vomiting in the Emergency DepartmentStatus: Completed, Estimated PCD: 2023-05-22
Clinical trial
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone. Can This Modality Improve the Antiemetic EffectStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
The Effects of Intravenous Fosaprepitant and Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Thoracicsurgery Patients: A Single-center, Randomized, Double-Blinded Clinical StudyStatus: Not yet recruiting, Estimated PCD: 2023-06-01
Clinical trial
BMT-08: A Comparative Effectiveness Study of the Efficacy and Safety of Transdermal Granisetron to Ondansetron in the Prevention of Nausea and Vomiting in Patients Undergoing Preparative Chemotherapy and Hematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
Ondansetron for the Treatment of Heavy Drinking Among Emerging AdultsStatus: Terminated, Estimated PCD: 2016-09-01
Clinical trial
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled TrialStatus: Completed, Estimated PCD: 2021-11-08
Clinical trial
Trial of Ondansetron as a Parkinson's HAllucinations TreatmentStatus: Active (not recruiting), Estimated PCD: 2024-08-30
Clinical trial
Timing of Ondansetron Use for Maximum Efficacy in Preventing Pruritus In Patients Undergoing Cesarean Section Under Spinal Anesthesia With Preservative Free Morphine.Status: Not yet recruiting, Estimated PCD: 2024-08-01
Clinical trial
Single-Dose Fasting In Vivo Bioequivalence Study of Ondansetron Tablets (24 mg; Mylan) and Zofran® Tablets (24 mg; GSK) in Healthy VolunteersStatus: Completed, Estimated PCD: 2003-07-01
Clinical trial
Single-Dose Food In Vivo Bioequivalence Study of Ondansetron Tablets (24 mg; Mylan) and Zofran® Tablets (24 mg; GSK) in Healthy VolunteersStatus: Completed, Estimated PCD: 2003-07-01
Clinical trial
1/2 - Pharmacogenetic Treatments for AlcoholismStatus: Withdrawn, Estimated PCD: 2017-12-01
Clinical trial
Hyoscine Butyl-bromide Versus Ondansetron for Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia: A Randomized Clinical TrialStatus: Completed, Estimated PCD: 2022-12-12
Clinical trial
The Effect of an Ondansetron on Blood Coagulation: In Vitro, Volunteer Study Using Rotational ThromboelastometryStatus: Recruiting, Estimated PCD: 2023-11-15
Clinical trial
The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic ShockStatus: Recruiting, Estimated PCD: 2023-06-01
Clinical trial
Comparison of Anti-nausea and Vomiting Effect After Elective Surgery Undergoing General Anesthesia Between Glycopyrronium and Ondansetron: a Multi-center StudyStatus: , Estimated PCD: 2023-05-30
Clinical trial
Validating the Effect of Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum: A Double-Blind Randomised Placebo-Controlled Multicentre TrialStatus: Terminated, Estimated PCD: 2022-07-31
Clinical trial
Dexamethasone vs Ondansetron as the First-line Antiemetic to Prevent Postoperative Nausea and Vomiting After Cesarean DeliveryStatus: Completed, Estimated PCD: 2024-04-30
Clinical trial
A Multicenter, Open-label, Randomized Controlled Clinical Study of the Efficacy and Safety of Ondansetron Oral Soluble Pellicles for the Prevention of Delayed Nausea and Vomiting Induced by Highly Emetogenic ChemotherapyStatus: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Single-Dose Fasting In Vivo Bioequivalence Study of Ondansetron Orally Disintegrating Tablets (8 mg; Mylan) to Zofran ODT® Tablets (8 mg; GlaxoSmithKline) in Healthy VolunteersStatus: Completed, Estimated PCD: 2005-07-01
Clinical trial
Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Pediatrics Undergoing Squint Surgeries: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Preoperative Ondansetron Lozenge for Prevention of Post-Spinal Shivering in Caesarean Section: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Organization
Natco Pharma Limited